Thromb Haemost 2008; 99(06): 1112-1115
DOI: 10.1160/TH08-02-0115
New Technologies, Diagnostic Tools and Drugs
Schattauer GmbH

Limited diagnostic workup for deep vein thrombosis after major joint surgery

Findings from a prospective, multicentre, cohort study
Manuel Monreal
1   Servicio de Medicina Interna, Hospital Universitari Germans Trias i Pujol, Badalona, Spain
,
Luis Peidro
2   Servicio de Cirugía Ortopédica y Traumatología, Hospital Clinic de Barcelona, Spain
,
Carlos Resines
3   Servicio de Cirugía Ortopédica y Traumatología, Hospital 12 de Octubre, Madrid, Spain
,
Carlos Garcés
4   Servicio de Cirugía Ortopédica y Traumatología, Hospital Marqués de Valdecilla, Cantabria, Spain
,
José Luís Fernández
5   Servicio de Cirugía Ortopédica y Traumatología, Hospital Xeral Cies, Pontevedra, Spain
,
Eduardo Garagorri
6   Servicio de Cirugía Ortopédica y Traumatología, Hospital Ramón y Cajal, Madrid, Spain
,
Juan Carlos González
7   Servicio de Cirugía Ortopédica y Traumatología, Hospital General de Albacete, Albacete, Spain
,
for the NETCOT Investigators › Author Affiliations
Further Information

Publication History

Received 27 February 2008

Accepted after minor revision 14 April 2008

Publication Date:
28 November 2017 (online)

Summary

While deep vein thrombosis (DVT) may be clinically suspected at several time points after major orthopedic surgery, clinical examination is often unreliable, and compression ultrasonography (CUS) screening at discharge is of limited value. A prospective cohort study was carried out in 1,033 consecutive patients who had undergone major hip or knee surgery, aimed to assess the accuracy of a strategy consisting of clinical investigation followed by CUS in the detection of proximal DVT before discharge. The circumferences of both legs were measured in all patients; those exhibiting >2 cm difference between them were considered to have suspected DVT, and underwent bilateral CUS. The same diagnostic workup was repeated on days 45 and 90 after surgery. Three patients developed pulmonary embolism (PE) during admission (one died). Five additional patients died before discharge. Routine clinical evaluation before discharge was done in 1,025 patients, and 105 (10%) had suspected DVT. CUS confirmed the diagnosis in 24 (2.3% of the overall series). After discharge, 59 patients had suspected DVT on day 45, 53 on day 90. DVT diagnosis was confirmed by CUS in 27 (26%).Three additional patients developed PE (1 fatal). This translates into a sensitivity of the routine examinations at discharge of 44%. A limited diagnostic workup for DVT before discharge has the capacity to identify 44% of those patients who will become symptomatic afterwards.

* A full list of NETCOT investigators is given in the appendix.


 
  • References

  • 1 Geerts WH, Pineo GF, Heit JA. et al. Prevention of venous thromboembolism. The Seventh ACCP Conference on antithrombotic and thrombolytic therapy. Chest 2004; 126: 338S-400S.
  • 2 Mohr D, Silverstein M, Murtaugh P, Harrison J. Prophylactic agents for venous thrombosis in elective hip surgery: Meta-analysis of studies using venographic assessment. Arch Intern Med 1993; 153: 2221-2228.
  • 3 White RH, Romano PS, Zhou H. et al. Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty. Arch Intern Med 1998; 158: 1525-1531.
  • 4 Quinlan DJ, Eikelboom JW, Dahl OE. et al. Association between asymptomatic deep vein thrombosis detected by venography and symptomatic venous thromboembolism in patients undergoing elective hip or knee surgery. J Thromb Haemost 2007; 5: 1438-1443.
  • 5 Eriksson BI, Bauer KA, Lassen MR. et al. for the Steering Committee of the Pentasaccharide in Hip Fracture Surgery Study. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery. N Engl J Med 2001; 345: 1298-1304.
  • 6 Bauer KA, Eriksson BI, Lassen MR. et al. for the Steering Committee of the Pentasaccharide in Major Knee Surgery Study. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery. N Engl J Med 2001; 345: 1305-1310.
  • 7 Planes A, Vochelle N, Darmon JY. et al. Risk of deep venous thrombosis after hospital discharge in patients having undergone total hip replacement: doubleblind randomized comparison of enoxaparin versus placebo. The Lancet 1996; 348: 224-228.
  • 8 Bergqvist D, Benoni G, Bjorgell O. et al. Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement. N Engl J Med 1996; 335: 696-700.
  • 9 Monreal M, Lafoz E, Roca J. et al. Platelet count, antiplatelet therapy and pulmonary embolism. A prospective study in patients with hip surgery. Thromb Haemost 1995; 73: 380-385.
  • 10 Wells PS, Lensing AWA, Davidson BL. et al. Accuracy of ultrasound for diagnosis of deep venous thrombosis in asymptomatic patients after orthopedic surgery. A meta-analysis. Ann Intern Med 1995; 122: 47-53.
  • 11 Robinson KS, Anderson DR, Gross M. et al. Ultrasonographic screening before hospital discharge for deep venous thrombosis after arthroplasty: the postarthroplasty screening study. A randomized, controlled trial. Ann Intern Med 1997; 127: 439-445.
  • 12 Leclerc JR, Gent M, Hirsh J. et al. for the Canadian Collaborative Group. The incidence of symptomatic venous thromboembolism during and after prophylaxis with enoxaparin. A multi-institutional cohort study of patients who underwent hip or knee arthroplasty. Arch Intern Med 1998; 158: 873-878.
  • 13 Verlato F, Bruchi O, Prandoni P. et al. for the WODOS Investigators Group. The value of ultrasound screening for proximal vein thrombosis after total hip arthroplasty. A prospective cohort study. Thromb Haemost 2001; 86: 534-537.
  • 14 Prandoni P, Bruchi O, Sabbion P. et al. Prolonged thromboprophylaxis with oral anticoagulants after total hip arthroplasty. A prospective controlled randomized study. Arch Intern Med 2002; 162: 1966-1971.
  • 15 Schmidt B, Michler R, Klein M. et al. Ultrasound screening for distal vein thrombosis is not beneficial after major orthopedic surgery. A randomized controlled trial. Thromb Haemost 2003; 90: 949-954.
  • 16 Schellong SM, Beyer J, Kakkar AK. et al. Ultrasound screening for asymptomatic deep vein thrombosis after major orthopaedic surgery: the VENUS study. J Thromb Haemost 2007; 5: 1431-1437.
  • 17 Bjornara BT, Gudmundsen TE, Dahl OE. Frequency of clinical venous thromboembolism after major joint surgery. J Bone Joint Surg (Br) 2006; 88B: 386-391.